Urolithiasis under atazanavir boosted and tenofovir therapy: a case report

J Chemother. 2008 Feb;20(1):143-4. doi: 10.1179/joc.2008.20.1.143.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Adult
  • Anti-HIV Agents / therapeutic use
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Atazanavir Sulfate
  • HIV Infections / drug therapy*
  • Humans
  • Male
  • Oligopeptides / adverse effects*
  • Oligopeptides / therapeutic use
  • Organophosphonates / adverse effects*
  • Organophosphonates / therapeutic use
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use
  • Ritonavir / adverse effects*
  • Ritonavir / therapeutic use
  • Tenofovir
  • Urolithiasis / chemically induced*
  • Viral Load

Substances

  • Anti-HIV Agents
  • Antiviral Agents
  • Oligopeptides
  • Organophosphonates
  • Pyridines
  • Atazanavir Sulfate
  • Tenofovir
  • Adenine
  • Ritonavir